Page 226 - Read Online

Sahulee et al. Vessel Plus 2022;6:5 https://dx.doi.org/10.20517/2574-1209.2021.94 Page 9 of 10

Cardiothorac Vasc Anesth 2011;25:419-24. DOI PubMed
18. Burkhardt BE, Rücker G, Stiller B. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children
undergoing surgery for congenital heart disease. Cochrane Database Syst Rev 2015;3:CD009515. DOI PubMed
19. Appelbaum A, Blackstone EH, Kouchoukos NT, Kirklin JW. Afterload reduction and cardiac output in infants early after intracardiac
surgery. Am J Cardiol 1977;39:445-51. DOI PubMed
20. Ranadive SM, Eugene AR, Dillon G, Nicholson WT, Joyner MJ. Comparison of the vasodilatory effects of sodium nitroprusside vs.
nitroglycerin. J Appl Physiol (1985) 2017;123:402-6. DOI PubMed PMC
21. Stone ML, Kelly J, Mistry M, Buck M, Gangemi J, Vergales J. Use of nicardipine after cardiac operations is safe in children regardless
of age. Ann Thorac Surg 2018;105:181-5. DOI PubMed
22. Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive
heart failure. Nesiritide Study Group. N Engl J Med 2000;343:246-53. DOI PubMed
23. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs
nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002;287:1531-40. DOI
PubMed
24. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated
heart failure: a pooled analysis of randomized controlled trials. JAMA 2005;293:1900-5. DOI PubMed
25. Tweddell JS, Hoffman GM, Mussatto KA, et al. Improved survival of patients undergoing palliation of hypoplastic left heart
syndrome: lessons learned from 115 consecutive patients. Circulation 2002;106:I82-9. PubMed
26. Miller OI, Tang SF, Keech A, Pigott NB, Beller E, Celermajer DS. Inhaled nitric oxide and prevention of pulmonary hypertension
after congenital heart surgery: a randomised double-blind study. Lancet 2000;356:1464-9. DOI PubMed
27. James C, Millar J, Horton S, Brizard C, Molesworth C, Butt W. Nitric oxide administration during paediatric cardiopulmonary bypass:
a randomised controlled trial. Intensive Care Med 2016;42:1744-52. DOI PubMed
28. Kirbas A, Yalcin Y, Tanrikulu N, Gürer O, Isik O. Comparison of inhaled nitric oxide and aerosolized iloprost in pulmonary
hypertension in children with congenital heart surgery. Cardiol J 2012;19:387-94. DOI PubMed
29. Wong J, Loomba RS, Evey L, Bronicki RA, Flores S. Postoperative inhaled nitric oxide does not decrease length of stay in pediatric
cardiac surgery admissions. Pediatr Cardiol 2019;40:1559-68. DOI PubMed
30. Smith HA, Canter JA, Christian KG, et al. Nitric oxide precursors and congenital heart surgery: a randomized controlled trial of oral
citrulline. J Thorac Cardiovasc Surg 2006;132:58-65. DOI PubMed
31. Bizzarro M, Gross I, Barbosa FT. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and
children with congenital heart disease. Cochrane Database Syst Rev 2014:CD005055. DOI PubMed
32. Schlapbach LJ, Horton SB, Long DA, et al; NITRIC Study Group, the Australian and New Zealand Intensive Care Society Clinical
Trials Group (ANZICS CTG), the Paediatric Critical Care Research group (PCCRG) and the ANZICS Paediatric Study Group (PSG).
Study protocol: NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC
trial): a randomised controlled trial. BMJ Open 2019;9:e026664. DOI PubMed PMC
33. Graham EM, Atz AM, Butts RJ, et al. Standardized preoperative corticosteroid treatment in neonates undergoing cardiac surgery:
results from a randomized trial. J Thorac Cardiovasc Surg 2011;142:1523-9. DOI PubMed PMC
34. Shore S, Nelson DP, Pearl JM, et al. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants
with congenital heart disease. Am J Cardiol 2001;88:591-4. DOI PubMed
35. Hall RI, Smith MS, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and
pharmacological considerations. Anesth Analg 1997;85:766-82. DOI PubMed
36. Li Y, Luo Q, Wu X, Jia Y, Yan F. Perioperative corticosteroid therapy in children undergoing cardiac surgery: a systematic review and
meta-analysis. Front Pediatr 2020;8:350. DOI PubMed PMC
37. Graham EM, Martin RH, Buckley JR, et al. Corticosteroid therapy in neonates undergoing cardiopulmonary bypass: randomized
controlled trial. J Am Coll Cardiol 2019;74:659-68. DOI PubMed PMC
38. Flores S, FitzGerald MR, Iliopoulos I, et al. An international survey of corticosteroid use for the management of low cardiac output
syndrome. Pediatr Crit Care Med 2017;18:630-7. DOI PubMed PMC
39. Hill KD, Baldwin HS, Bichel DP, et al; STRESS Network Investigators. Rationale and design of the STeroids to REduce Systemic
inflammation after infant heart Surgery (STRESS) trial. Am Heart J 2020;220:192-202. DOI PubMed PMC
40. Bettendorf M, Schmidt KG, Tiefenbacher U, Grulich-Henn J, Heinrich UE, Schönberg DK. Transient secondary hypothyroidism in
children after cardiac surgery. Pediatr Res 1997;41:375-9. DOI PubMed
41. Mackie AS, Booth KL, Newburger JW, et al. A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal
heart surgery. J Thorac Cardiovasc Surg 2005;130:810-6. DOI PubMed
42. Marwali EM, Caesa P, Darmaputri S, et al. Oral Triiodothyronine supplementation decreases low cardiac output syndrome after
pediatric cardiac surgery. Pediatr Cardiol 2019;40:1238-46. DOI PubMed
43. Portman MA, Slee A, Olson AK, et al; TRICC Investigators. Triiodothyronine supplementation in infants and children undergoing
cardiopulmonary bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis. Circulation 2010;122:S224-33.
DOI PubMed PMC
44. Marwali EM, Boom CE, Budiwardhana N, et al. Oral triiodothyronine for infants and children undergoing cardiopulmonary bypass.
Ann Thorac Surg 2017;104:688-95. DOI PubMed
45. Flores S, Loomba RS, Checchia PA, Graham EM, Bronicki RA. Thyroid hormone (triiodothyronine) therapy in children after
congenital heart surgery: a meta-analysis. Semin Thorac Cardiovasc Surg 2020;32:87-95. DOI PubMed